Pharmacokinetics, pharmacodynamics, and safety of pasireotide LAR in patients with acromegaly: A randomized, multicenter, open-label, phase I study-Reference-Cited by-同舟云学术

Pharmacokinetics, pharmacodynamics, and safety of pasireotide LAR in patients with acromegaly: A randomized, multicenter, open-label, phase I study

Published:2014-05-24 Issue:11 Volume:54 Page:1308-1317
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Petersenn Stephan¹,Bollerslev Jens²,Arafat Ayman M.³,Schopohl Jochen⁴,Serri Omar⁵,Katznelson Laurence⁶,Lasher Janet⁷,Hughes Gareth⁷,Hu Ke⁷,Shen George⁷,Reséndiz Karina Hermosillo⁷,Giannone Vanessa⁷,Beckers Albert⁸

Affiliation:

1. ENDOC Center for Endocrine Tumors; Hamburg Germany

2. Oslo University Hospital; Section of Specialized Endocrinology, Medical Clinic B and Faculty of Medicine, University of Oslo; Oslo Norway

3. Department of Endocrinology; Diabetes and Nutrition, Charité-University Medicine Berlin, Campus Benjamin Franklin; Berlin Germany

4. Medizinische Klinik IV; Campus Innenstadt, University of Munich; Munich Germany

5. CHUM, Notre-Dame Hospital; Montreal Quebec Canada

6. Division of Endocrinology and Metabolism; Stanford University School of Medicine; Stanford CA USA

7. Novartis Pharmaceuticals Corporation; East Hanover NJ USA

8. CHU de Liège; Domaine Universitaire du Sart-Tilman Liège; Liège Belgium

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.326/fullpdf

Reference19 articles.

1. Acromegaly;Chanson;Orphanet J Rare Dis,2008

2. Medical progress: acromegaly;Melmed;N Engl J Med,2006

3. Guidelines for acromegaly management: an update;Melmed;J Clin Endocrinol Metab,2009

4. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile;Bruns;Eur J Endocrinol,2002

5. A 12-month Phase 3 study of pasireotide in Cushing's disease;Colao;N Engl J Med,2012

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and pharmacodynamics of a pasireotide subcutaneous depot (CAM4071) and comparison with immediate and long-acting release pasireotide;Endocrine;2024-02-29

2. Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults;Cochrane Database of Systematic Reviews;2024-02-06

3. Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up;Journal of Endocrinological Investigation;2024-01-20

4. Healthy pregnancy in a woman with GH-secreting pituitary macroadenoma treated with pasireotide;Annales d'Endocrinologie;2023-08

5. Medical management of Cushing's disease: When and how?;Journal of Neuroendocrinology;2022-03-29